2014
Dec 2014 | Download as pdf St. Cloud Surgical Center is First ASC in U.S. to Utilize Xenex Germ-Zapping Robot to Disinfect Operating Rooms & Enhance Patient Safety more |
Dec 2014 | Download as pdf 4 cheap small cap stocks I’ve got my eye for Christmas more |
Dec 2014 | Download as pdf Southern Biologics Network Established to Create Biologics Faster and Less Expensively more |
Dec 2014 | Download as pdf Morningside Ministries at the Manor is the First Skilled Nursing Facility in Texas to Protect Residents with Xenex Germ-Zapping Robot more |
Dec 2014 | Download as pdf RBA to cut rates in 2015: Still want to invest in term deposits? more |
Nov 2014 | Download as pdf Can robots help stop the Ebola outbreak? more |
Nov 2014 | Download as pdf Robots Help Fight Ebola Using four wheels and ultraviolet (UV) light, robots may be a key player in helping to fight Ebola. Called the pulsed Xenon UV Disinfection system by its manufacturer, these robots clean hospital facilities more efficiently and thoroughly than a human-staffed cleaning crew. The robots are manufactured by Xenex Disinfection Services, a company located in San Antonio, Texas, and are starting to prove essential for sterilized environments. Appearing like a tall R2D2 from Star Wars, the drones currently operate in three military medical centers treating Ebola and 250 other U.S. hospitals. Ultraviolent light comes in three types: UV-A, UV-B, and UV-C. The A and B types exist naturally on Earth and are best known causing sunburns. UV-C is filtered out by ozone layer and does not exist in nature. As such, bacteria and viruses have no defense against it and when exposed to those rays, the infectious organisms die. Xenex robots send out 1.5 pulses of UV-C light per second around a 10-foot radius. It takes about five minutes to thoroughly clean a room and the light penetrates tight spots that are either overlooked or inaccessible to humans. Using UV light to disinfect is not a new technology. Previously, UV light was produced by mercury vapor bulbs that were not only toxic but slow acting, making it an unsuitable means of keeping hospitals clean. The new technology uses Xenon, which is a non-toxic gas. It can create the rays and eradicate germs much more quickly than any previous UV technology. To use them, the robot is wheeled in the room by a human operator. The operator leaves the device in the room, closes the door, and activates it remotely. This precaution is necessary since UV-C rays can cause eye damage. UV-C cannot penetrate windows, walls, or glass but as an extra safety precaution, the robot deactivates immediately if it detects motion. Besides disinfection, other applications are also being considered for robots so they can help fight Ebola. With human contact being the primary means of spreading the infection, robots can facilitate interviews between patients and health workers. They can also haul biohazard waste and even move living patients or dead bodies. One possibility for these applications is already being considered. The General Dynamics Land Systems MUTT is a robotic wagon that could be retrofit for medical purposes and help West African and U.S. military health workers. However, challenges remain as hospitals in West Africa do not offer the same pristine conditions these robots are designed for including flat floors, Wi-Fi access, enough electricity, and batteries. While applications are recognized, there are no plans to send robots to West African hospitals as of yet. However, they are used in the military facilities where health care workers find them efficient and reassuring. The Xenex robots can not only help fight Ebola, but they are proving essential for controlling opportunistic infections in hospitals. The rate of hospital-contracted infections steadily increased even in advanced Western countries, putting additional strain on medical resources. Hospitals that started using Xenex’s UV-C technology reported a significant reduction in secondary infections. |
Nov 2014 | Download as pdf South Florida Hospital Unveils Ebola-Zapping Robot more |
Nov 2014 | Download as pdf Sonoma Valley Hospital uses robot to kill germs more |
Nov 2014 | Download as pdf Robots go to war against Ebola more |
Nov 2014 | Download as pdf New iTraumaCare CEO to pursue big growth more |
Nov 2014 | Download as pdf UAB and SRI have plans to spinoff more success more |
Nov 2014 | Download as pdf Launch of Galderma's new acne products more |
Nov 2014 | Download as pdf iTraumaCare’s new CEO to help company secure new funding more |
Oct 2014 | Download as pdf U.S. Air Force Hospital Langley Adds Xenex Ebola-Zapping Robot to Inventory more |
Oct 2014 | Download as pdf Forthcoming Acne Treatment Made With Exclusive (And Sustainable) East Indian Sandalwood Oil more |
Oct 2014 | Download as pdf Sonoma Valley Hospital Acquires Xenex Germ-Killing Robot to Enhance Patient Safety more |
Oct 2014 | Download as pdf Robot fights germs at Sharp Chula Vista Medical Center more |
Oct 2014 | Download as pdf Xenex updates protocols for germ-zapping robots in response to Ebola threat more |
Oct 2014 | Download as pdf How do we get rid of the endotoxins? Birmingham's has the solution more |
Oct 2014 | Download as pdf Medical Device ® Positions New Leader for Next-Level Growth more |
Oct 2014 | The Xenex robot at South Shore Hospital featured on an Xploration Earth more |
Oct 2014 | Download as pdf Germ-zapping robot Gigi sets its sights on Ebola more |
Oct 2014 | Download as pdf Morningside Ventures leads a Series B round for DNAtrix more |
Oct 2014 | Download as pdf StemBioSys secures new research space at BioBridge Global more |
Oct 2014 | Download as pdf Birmingham's Soluble Therapeutics acquires Seattle company Dilyx Biotechnology more |
Oct 2014 | Download as pdf Company invents germ-zapping robot more |
Sept 2014 | Download as pdf Xenex Congratulates Houston Cancer Hospital more |
Sept 2014 | Download as pdf Australian grown Indian Sandalwood timber attracts lucrative Asian markets more |
Sept 2014 | Download as pdf DNATRIX ANNOUNCES TREATMENT OF FIRST PATIENT WITH DNX-2401 more |
Sept 2014 | Download as pdf Targeted Technology raises more than $40 million more |
Sept 2014 | Download as pdf Reducing Healthcare Associated Infections (HAIs): Not All UV Light is the Same more |
Sept 2014 | Download as pdf Bluegrass Vascular Technologies Names Dr. Gabriele Niederauer President And CEO more |
Aug 2014 | Download as pdf Three Birmingham companies recognized in PwC report more |
Aug 2014 | Download as pdf Former Kinetic Concepts Inc. CEO to lead StemBioSys more |
Aug 2014 | Download as pdf International dermatology company Galderma confirmed more |
Aug 2014 | Download as pdf AUSTRALIAN Sandalwood producer TFS Corporation will supply oil more |
Aug 2014 | Download as pdf San Antonio luring biotech firms with venture capital more |
July 2014 | Download as pdf Biotech firm secures nearly $5 million in funding, is relocating to San Antonio more |
July 2014 | Download as pdf Birmingham is on the front lines of medical research: take a look at this incredible biotech startup more |
July 2014 | Download as pdf Germ-Zapping Robots Fight C. diff and MRSA at Mercy Health Saint Mary's more |
July 2014 | Download as pdf Milford hospital enlists robots in war against infections more |
July 2014 | Download as pdf Xenex Testifies About UV Room Disinfection Technology Effectiveness to U.S. House of Representatives more |
July 2014 | Download as pdf Western Pa. hospitals test robot using ultraviolet rays to kill bacteria more |
July 2014 | Download as pdf Xenex Demonstrates UV Room Cleaning System’s Effectiveness in Reducing Hospital Acquired Infections more |
July 2014 | Download as pdf TFS flags record full-year profit more |
June 2014 | Download as pdf Sweet scented sandalwood flavour of month more |
June 2014 | Download as pdf House committee looks for new technology in Veterans Affairs hospitals more |
June 2014 | Download as pdf FDA grants fast track status to drug DNX-2401 for recurrent Glioblastoma more |
May 2014 | Download as pdf CEO shakeup at San Antonio biotech company StemBioSys more |
May 2014 | Download as pdf First harvest to be completed in June more |
Mar 2014 | Download as pdf BiO2 Medical Enrolls Subjects in the New U.S. FDA Early Feasibility Pilot Study for the Angel® Catheter more |
Mar 2014 | Download as pdf San Antonio biotech firm readies skin treatment for distribution more |
Mar 2014 | Download as pdf ViroXis Gets Approval To Initiate FDA Phase 2 Study For Molluscum Contagiosum more |
Mar 2014 | Download as pdf Medical technologies conference announces speaker lineup more |
Mar 2014 | Download as pdf Australian sandalwood sells for millions more |
Mar 2014 | Download as pdf Sandalwood exports as good as gold more |
Feb 2014 | Download as pdf Santalis Pharmaceuticals Signs Exclusive License Agreement with Global Pharmaceutical Company to Commercialize OTC Dermatology Products more |
Feb 2014 | Download as pdf ViroXis Corporation Signs Exclusive License Agreement with Global Pharmaceutical Company to Commercialize an OTC Dermatology Product more |
Feb 2014 | Download as pdf DNAtrix Awarded $10.8 Million Grant by the Cancer Prevention and Research Institute of Texas more |
Feb 2014 | Download as pdf ViroXis Corporation Achieves Key Clinical Milestones more |
Jan 2014 | Download as pdf There are growing concerns about the threat of an antibiotic crisis caused by the spread of drug-resistant superbugs. Those concerns could result in more |